LAYLA ERICSON: Open Payments
NPI 1285304378 · BEND, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$399 in 14 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $62 · 2025 $399
Food & beverage: $399
| Company | Payments | Amount |
|---|---|---|
| UROGEN PHARMA, INC. | 3 | $81 |
| Sumitomo Pharma America, Inc. | 1 | $65 |
| TOLMAR, INC. | 1 | $53 |
| Olympus America Inc. | 2 | $50 |
| Janssen Biotech, Inc. | 2 | $43 |
| ABBVIE INC. | 2 | $42 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $36 |
| 180 Medical, Inc. | 1 | $30 |
Products named: GEMTESA, RUBRACA, iTIND System, ERLEADA, BOTOX, Nubeqa, CURE CATHETER, JELMYTO.
Industry payments across OR — which companies pay providers there.
